Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Church & Dwight antiperspirants

This article was originally published in The Tan Sheet

Executive Summary

Arm & Hammer Ultra Max antiperspirant/deodorant with "unique time-released baking soda technology" to begin shipping in early February, firm says. Packaging for re-staged line will be larger, more modern than existing offering; advertising/promotional campaign expected to break in May. TV spots supporting C&D's recently launched Arm & Hammer Advance Breath Care system with toothpaste, mouthwash, gum, mints broke Nov. 1; FSI dropped Nov. 4. Ads stress products' "three hour power to keep breath fresher longer." Firm expects line to generate$65 mil. in first-year sales (1"The Tan Sheet" July 16, p. 6)...

Arm & Hammer Ultra Max antiperspirant/deodorant with "unique time-released baking soda technology" to begin shipping in early February, firm says. Packaging for re-staged line will be larger, more modern than existing offering; advertising/promotional campaign expected to break in May. TV spots supporting C&D's recently launched Arm & Hammer Advance Breath Care system with toothpaste, mouthwash, gum, mints broke Nov. 1; FSI dropped Nov. 4. Ads stress products' "three hour power to keep breath fresher longer." Firm expects line to generate$65 mil. in first-year sales (1 (Also see "Arm & Hammer Advance Breath Care Line To Generate $65 Mil. In First Year" - Pink Sheet, 16 Jul, 2001.), p. 6)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093250

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel